SEARCH

SEARCH BY CITATION

References

  • 1
    Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76: 514519.
  • 2
    Zhang D, Zhang G, Hayden MS et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 15221526.
  • 3
    Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004; 5: 975979.
  • 4
    Peng Y, Gong JP, Liu CA, Li XH, Gan L, Li SB. Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol 2004; 10: 28902903.
  • 5
    Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O. Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004; 3: 250253.
  • 6
    Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury—a fresh look. Exp Mol Pathol 2003; 74: 8693.
  • 7
    Zhai Y, Shen XD, O'Connell R et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFNγ regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 71157119.
  • 8
    Beg AA. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23: 509512.
  • 9
    Termeer C, Benedix F, Sleeman J et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99111.
  • 10
    De Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, Van Heurn LW, Buurman WA. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004; 165: 16771688.
  • 11
    Collard CD, Vakeva A, Morrissey MA et al. Complement activation after oxidative stress: Role of the lectin complement pathway. Am J Pathol 2000; 156: 15491556.
  • 12
    Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582587.
  • 13
    Fearon DT, Carroll MC. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol 2000; 18: 393422.
  • 14
    Hawlisch H, Wills-Karp M, Karp CL, Kohl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol 2004; 41: 123131.
  • 15
    Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388392.
  • 16
    Heeger PS, Lalli PN, Lin F et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201: 15231530.
  • 17
    Moberg L. The role of the innate immunity in islet transplantation. Ups J Med Sci 2005; 110: 1755.
  • 18
    Johansson U, Elgue G, Nilsson B, Korsgren O. Composite islet-endothelial cell grafts: A novel approach to counteract innate immunity in islet transplantation. Am J Transplant 2005;: 26322639.
  • 19
    Moser B, Wolf M, Walz A, Loetscher P. Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 7584.
  • 20
    Chen D, Ding Y, Zhang N et al. Viral IL-10 gene transfer inhibits the expression of multiple chemokine and chemokine receptor genes induced by inflammatory or adaptive immune stimuli. Am J Transplant 2003; 3: 15381549.
  • 21
    Loi P, Paulart F, Pajak B et al. The fate of dendritic cells in a mouse model of liver ischemia/reperfusion injury. Transplant Proc 2004; 36: 12751279.
  • 22
    Zhang J, Yu ZX, Fujita S, Yamaguchi ML, Ferrans VJ. Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction. Circulation 1993; 87: 909920.
  • 23
    Samstein B, Johnson GB, Platt JL. Toll-like receptor-4 and allograft responses. Transplantation 2004; 77: 475487.
  • 24
    Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987995.
  • 25
    Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947950.
  • 26
    Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10 (−/−) setting. Immunity 2002; 16: 429439.
  • 27
    Coates PT, Duncan FJ, Colvin BL et al. In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T cell responses, and prolong organ allograft survival. Transplantation 2004; 77: 10801089.
  • 28
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 10331036.
  • 29
    Yang Y, Huang CT, Huang X, Pardoll DM. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 2004; 5: 508515.
  • 30
    Christopher K, Mueller TF, Ma C, Liang Y, Perkins DL. Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 2002; 169: 522530.
  • 31
    Hutchings A, Wu J, Asiedu C et al. The immune decision toward allograft tolerance in non-human primates requires early inhibition of innate immunity and induction of immune regulation. Transpl Immunol 2003; 11: 335344.
  • 32
    He H, Stone JR, Perkins DL. Analysis of differential immune responses induced by innate and adaptive immunity following transplantation. Immunology 2003; 109: 185196.
  • 33
    Ysebaert DK, De Greef KE, De Beuf A et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004; 66: 491496.
  • 34
    Halloran PF, Miller LW, Urmson J et al. IFN-gamma alters the pathology of graft rejection: Protection from early necrosis. J Immunol 2001; 166: 70727081.
  • 35
    El-Sawy T, Miura M, Fairchild R. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 2004; 165: 147157.
  • 36
    Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 18871895.
  • 37
    Price PM, Megyesi J, Safirstein RL. Cell cycle regulation: Repair and regeneration in acute renal failure. Kidney Int 2004; 66: 509514.
  • 38
    Lagaaij EL, Cramer-Knijnenburg GF, Van Kemenade FJ, Van Es LA, Bruijn JA, Van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 3337.
  • 39
    Penn MS, Zhang M, Deglurkar I, Topol EJ. Role of stem cell homing in myocardial regeneration. Nat Med 2003; 9: 13701376.
  • 40
    Tang YL, Qian K, Zhang YC, Shen L, Phillips MI. Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment. Regul Pept 2005; 125: 18.
  • 41
    Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 13701376.